Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
CPhI India 2024CPhI India 2024
Not Confirmed
Not Confirmed
26-28 November, 2024
AusBiotech 2024AusBiotech 2024
Not Confirmed
Not Confirmed
30 October-02 November, 2024
Not Confirmed
Not Confirmed
03-06 November, 2024
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
CPhI India 2024CPhI India 2024
Industry Trade Show
Not Confirmed
26-28 November, 2024
AusBiotech 2024AusBiotech 2024
Industry Trade Show
Not Confirmed
30 October-02 November, 2024
Industry Trade Show
Not Confirmed
03-06 November, 2024
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/due-to-its-20-year-mastery-in-micronization-inke-has-emerged-a-cornerstone-in-treating-global-respiratory-diseases
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/dmf-filings-hit-all-time-high-in-q3-2024-china-tops-list-with-58-increase-in-type-ii-submissions
11 Sep 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/synaptogenix-announces-5-0-million-financing-302244690.html
18 Jul 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/synaptogenix-announces-new-collaboration-with-lsu-health-new-orleans-for-study-of-proprietary-analogs-in-spinal-cord-injury-302200323.html
26 Jun 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/synaptogenix-announces-fda-authorization-of-ind-application-for-clinical-trial-for-bryostatin-1-in-multiple-sclerosis-302182860.html
07 May 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/synaptogenix-applauds-dea-proposal-to-reclassify-cannabis-and-shares-expected-benefits-to-cannasoul-for-cannabinoid-based-drug-discovery-302137968.html
24 Apr 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/synaptogenix-regains-compliance-with-nasdaq-minimum-bid-price-requirement-for-continued-listing-302125770.html
09 Apr 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/synaptogenix-increases-stake-in-innovative-psilocybin-drug-discovery-company-through-its-partnership-with-cannasoul-analytics-302111691.html
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?